HER2 antibody composition

Details for Australian Patent Application No. 2005287404 (hide)

Owner Genentech, Inc.

Inventors Kao, Yung-Hsiang; Vanderlaan, Martin

Agent Griffith Hack

Pub. Number AU-B-2005287404

PCT Pub. Number WO2006/033700

Priority 60/590,202 22.07.04 US

Filing date 15 July 2005

Wipo publication date 30 March 2006

Acceptance publication date 7 May 2009

International Classifications

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/033700 Priority application(s): WO2006/033700

29 March 2007 Amendment Made

  The nature of the amendment is: Amend priority details from 50/590,202 22 Jul 2004 US to 60/590,202 22 Jul 2004 US 2005291607 SMS Demag AG The nature of the amendment is: Amend co-inventor name from Hausler, Jan Christoph to Haeusler, Jan Christoph 2006

7 May 2009 Application Accepted

  Published as AU-B-2005287404

3 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287406-Anti-CD154 antibodies

2005287402-Tissue matrix system